Research Site — Camden, New Jersey

Research Site is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Research Site has participated in 19 clinical trials with 11 currently active.

Therapeutic areas: Advanced Breast Cancer, Locally Advanced (Inoperable) or Metastatic Breast Cancer, Non-small Cell Lung Cancer.

Sponsors: AstraZeneca, Ambrx, Inc., Sanofi.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 19 clinical trials on record, with 11 currently active. Their work covers Advanced Breast Cancer, Locally Advanced (Inoperable) or Metastatic Breast Cancer, Non-small Cell Lung Cancer.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.